Additional information
| Active substance | Raloxifene |
|---|---|
| Water Retention | None |
| Hepatotoxicity | Low risk |
| Lab Test | Not specific, general liver function tests may be monitored |
| Also known as | Raloxifene hydrochloride |
| Blood pressure | Typically has no significant effect on blood pressure |
| Trade name | Evista |
| Storage conditions | Store at room temperature, protect from moisture and heat |
| Chemical name | [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride |
| Formula | C28H27NO4SВ·HCl |
| Substance class | Selective Estrogen Receptor Modulator (SERM) |
| Main action | Estrogen receptor modulator |
| Half-life | Approximately 27.7 hours |
| Dosage (medical) | Commonly prescribed as 60 mg per day |
| Dosage (sports) | Not typically used in sports for performance enhancement |
| Effects | Reduces the risk of osteoporosis, decreases total and LDL cholesterol |
| Side effects | Hot flashes, leg cramps, increased risk of venous thromboembolism, stroke |
| Use in sports | None, as it is not known for performance enhancement |
| Manufacturer | Euro-Pharmacies |
| Packing | 40 tabs (60mg/tab) |
AVELOX 400 Bayer
Avory Pharma Oral Turinabol 10 mg 100 Kapseln
Norvacs 10 mg Pfizer
Fostimon (Merional) 150 IU HMG IBSA
FACTIVE 320 mg Abdi Ibragim
Seretide Disckus (Advair) 250 mcg Glaxosmithkline 

Reviews
There are no reviews yet.